| Gene symbol | IL13RA2 | Synonyms | CD213A2, CT19, IL-13R, IL13BP | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq23 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | interleukin 13 receptor subunit alpha 2 | ||||
| GTO ID | GTC2424 |
| Trial ID | NCT04510051 |
| Disease | Brain Neoplasm |
| Altered gene | IL13RA2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | IL13Ra2 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children |
| Year | 2020 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 19130|NCI-2020-05158|19130|P30CA033572 |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||